Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP383674.RANTxJZ7LnVipZukY1n6jc_z-Ih7qOb1cHng88w6xuSFo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP383674.RANTxJZ7LnVipZukY1n6jc_z-Ih7qOb1cHng88w6xuSFo130_assertion type Assertion NP383674.RANTxJZ7LnVipZukY1n6jc_z-Ih7qOb1cHng88w6xuSFo130_head.
- NP383674.RANTxJZ7LnVipZukY1n6jc_z-Ih7qOb1cHng88w6xuSFo130_assertion description "[Currently, targeted therapies (tamoxifen) are only able to reduce DCIS risk in patients with estrogen receptor ? (ER?)-positive disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP383674.RANTxJZ7LnVipZukY1n6jc_z-Ih7qOb1cHng88w6xuSFo130_provenance.
- NP383674.RANTxJZ7LnVipZukY1n6jc_z-Ih7qOb1cHng88w6xuSFo130_assertion evidence source_evidence_literature NP383674.RANTxJZ7LnVipZukY1n6jc_z-Ih7qOb1cHng88w6xuSFo130_provenance.
- NP383674.RANTxJZ7LnVipZukY1n6jc_z-Ih7qOb1cHng88w6xuSFo130_assertion SIO_000772 23752191 NP383674.RANTxJZ7LnVipZukY1n6jc_z-Ih7qOb1cHng88w6xuSFo130_provenance.
- NP383674.RANTxJZ7LnVipZukY1n6jc_z-Ih7qOb1cHng88w6xuSFo130_assertion wasDerivedFrom befree-20150227 NP383674.RANTxJZ7LnVipZukY1n6jc_z-Ih7qOb1cHng88w6xuSFo130_provenance.
- NP383674.RANTxJZ7LnVipZukY1n6jc_z-Ih7qOb1cHng88w6xuSFo130_assertion wasGeneratedBy ECO_0000203 NP383674.RANTxJZ7LnVipZukY1n6jc_z-Ih7qOb1cHng88w6xuSFo130_provenance.